
Friday, April 3, 2026
The Gist Healthcare Podcast
00:00
Foundéo competes with Novo Nordisk's oral GLP-1
J. Carlisle Larsen compares Foundéo to Novo Nordisk's Wagovi and notes existing uptake of oral GLP-1 therapies.
Play episode from 03:13
Transcript


